Nencioni, Alessio
Università degli Studi di Genova,
Italy
2025 Rank: 197796
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 6092 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 197796 | 207894 |
| Total Cites | 703 | 776 |
| H-index | 12 | 12 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 85 | 94 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 301 | 335 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 598 | 625 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.24 |
| Self-Citation Percentage |
9.41%
|
|
Nencioni, Alessio
Università degli Studi di Genova,
Italy
2024 Rank: 181357
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 6009 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 181357 | 184575 |
| Total Cites | 639 | 734 |
| H-index | 12 | 13 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 95 | 100 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 271 | 310 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 540 | 570 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.29 |
| Self-Citation Percentage |
12.94%
|
|
Nencioni, Alessio
IRCCS San Martino Polyclinic Hospital,
Italy
2023 Rank: 158444
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5645 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 158444 | 172660 |
| Total Cites | 661 | 735 |
| H-index | 13 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 97 | 99 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 293 | 324 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 549 | 587 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.25 |
| Self-Citation Percentage |
10.07%
|
|
Nencioni, Alessio
IRCCS San Martino Polyclinic Hospital,
Italy
2022 Rank: 142075
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5357 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 142075 | 147358 |
| Total Cites | 669 | 753 |
| H-index | 14 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 100 | 108 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 297 | 328 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 551 | 600 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.26 |
| Self-Citation Percentage |
11.16%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.